Advent Life Sciences Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 9

Professionals

  • Investments
  • 112

  • Portfolio
  • 26

  • Exits
  • 48

Exits

Advent Life Sciences General Information

Company Description

Founded in 2005, Advent Life Sciences is a venture capital firm based in London, United Kingdom. The firm seeks to invest in life sciences businesses focusing on new drug discovery, small molecules, biologics, and new modalities, med tech, enabling technologies, and the vaccines sectors.

Business Details

Formerly Known As
Advent Ventures Life Sciences Llp, Advent Life Science Partners Llp
Year Founded
2005
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 27 Fitzroy Square
  • London W1T 6ES
  • England, United Kingdom
+44 020

Advent Life Sciences Investments (112)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
T-Therapeutics 05-Nov-2026 Early Stage VC Drug Discovery Pre-Clinical Trials
Glycomine 14-May-2026 Drug Discovery Clinical Trials - Phase 2
Artax Biopharma 30-Apr-2026 Drug Discovery Clinical Trials - Phase 2
Beacon Therapeutics 09-Jan-2026 Drug Discovery Clinical Trials - Phase 3
Cyted Health 29-Aug-2025 Diagnostic Equipment Generating Revenue
Relief Cardiovascular 26-Dec-2024 Therapeutic Devices Startup
Epitopea 24-Oct-2024 Drug Discovery Generating Revenue
Nalu Medical 09-Oct-2024 Therapeutic Devices Generating Revenue
AviadoBio 08-Oct-2024 Later Stage VC Drug Discovery Clinical Trials - Phase 2
F2G 12-Sep-2024 Later Stage VC Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 112 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advent Life Sciences Exits (48)

Company Name Exit Date Exit Type Exit Size
Nalu Medical 27-Jan-2026 Merger/Acquisition
Centessa Pharmaceuticals 14-Nov-2025
Alpha Anomeric 29-Apr-2025
MediGene 16-Apr-2025
MiroBio 20-Sep-2022
Aura Biosciences 02-Nov-2021
Centessa Pharmaceuticals 28-May-2021
Zikani Therapeutics 01-Apr-2021
Capella BioScience 16-Feb-2021 Merger/Acquisition
Iterum Therapeutics 26-Oct-2020 Public Investment 2nd Offering
You’re viewing 10 of 48 exits. Get the full list »

Advent Life Sciences Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Advent Life Sciences‘s full profile, request access.

Request a free trial

Advent Life Sciences Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Advent Life Sciences Co-Investors (106)

Name With Exits Lead Partner Series Industry
British Business Bank 4 Series chart Industry bar
F-Prime Series chart Industry bar
Gilde Healthcare Series chart Industry bar
Novo Holdings Series chart Industry bar
Forbion Series chart Industry bar
You’re viewing 5 of 106 co-investors. Get the full list »

Advent Life Sciences FAQs

  • What is Advent Life Sciences?

    Founded in 2005, Advent Life Sciences is a venture capital firm based in London, United Kingdom.

  • When was Advent Life Sciences founded?

    Advent Life Sciences was founded in 2005.

  • Where is Advent Life Sciences headquartered?

    Advent Life Sciences is headquartered in London, United Kingdom.

  • What is Advent Life Sciences's total asset value?

    Advent Life Sciences has around in total assets under management.

  • How many investments has Advent Life Sciences made?

    Advent Life Sciences has made 112 investments.

  • What has Advent Life Sciences invested in?

    Advent Life Sciences has made numerous investments in companies like T-Therapeutics, Glycomine, and Artax Biopharma within the Drug Discovery industry.

  • What has Advent Life Sciences invested in recently?

    Advent Life Sciences's latest investment was on 05-Nov-2026 in T-Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process